ArticleIn vivo (Athens, Greece)

Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.

Shan-Wen Lui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.